83 related articles for article (PubMed ID: 14980127)
1. [Review of recent research on hepatitis C therapy for 54th annual meeting of the American association for the study of liver diseases].
Wei L
Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):118-20. PubMed ID: 14980127
[No Abstract] [Full Text] [Related]
2. Hepatitis C drug being developed.
AIDS Patient Care STDS; 2004 Jan; 18(1):62. PubMed ID: 15080102
[No Abstract] [Full Text] [Related]
3. Viral kinetics in patients with chronic hepatitis C treated with the serine protease inhibitor BILN 2061.
Herrmann E; Zeuzem S; Sarrazin C; Hinrichsen H; Benhamou Y; Manns MP; Reiser M; Reesink H; Calleja JL; Forns X; Steinmann GG; Nehmiz G
Antivir Ther; 2006; 11(3):371-6. PubMed ID: 16759054
[TBL] [Abstract][Full Text] [Related]
4. Novel robust hepatitis C virus mouse efficacy model.
Zhu Q; Oei Y; Mendel DB; Garrett EN; Patawaran MB; Hollenbach PW; Aukerman SL; Weiner AJ
Antimicrob Agents Chemother; 2006 Oct; 50(10):3260-8. PubMed ID: 17005803
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C: it's a long way to new therapy, it's a long way to go..
Pawlotsky JM
Gastroenterology; 2004 Nov; 127(5):1629-32. PubMed ID: 15521029
[No Abstract] [Full Text] [Related]
6. Virology: fresh assault on hepatitis C.
Rice CM
Nature; 2003 Nov; 426(6963):129-31. PubMed ID: 14578912
[No Abstract] [Full Text] [Related]
7. "Strong reasons make strong actions"--The antiviral efficacy of NS3/4A protease inhibitors.
Lemon SM; Yi M; Li K
Hepatology; 2005 Mar; 41(3):671-4. PubMed ID: 15723328
[No Abstract] [Full Text] [Related]
8. Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis C.
Reiser M; Hinrichsen H; Benhamou Y; Reesink HW; Wedemeyer H; Avendano C; Riba N; Yong CL; Nehmiz G; Steinmann GG
Hepatology; 2005 Apr; 41(4):832-5. PubMed ID: 15732092
[TBL] [Abstract][Full Text] [Related]
9. Antiviral interactions of an HCV polymerase inhibitor with an HCV protease inhibitor or interferon in vitro.
Koev G; Dekhtyar T; Han L; Yan P; Ng TI; Lin CT; Mo H; Molla A
Antiviral Res; 2007 Jan; 73(1):78-83. PubMed ID: 16945431
[TBL] [Abstract][Full Text] [Related]
10. Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse.
Vanwolleghem T; Meuleman P; Libbrecht L; Roskams T; De Vos R; Leroux-Roels G
Gastroenterology; 2007 Oct; 133(4):1144-55. PubMed ID: 17919490
[TBL] [Abstract][Full Text] [Related]
11. The design of a potent inhibitor of the hepatitis C virus NS3 protease: BILN 2061--from the NMR tube to the clinic.
Tsantrizos YS
Biopolymers; 2004; 76(4):309-23. PubMed ID: 15386268
[TBL] [Abstract][Full Text] [Related]
12. Interferon-based therapy of hepatitis C.
Chevaliez S; Pawlotsky JM
Adv Drug Deliv Rev; 2007 Oct; 59(12):1222-41. PubMed ID: 17869375
[TBL] [Abstract][Full Text] [Related]
13. New therapeutic options for hepatitis C.
Waters L; Nelson M
Curr Opin Infect Dis; 2006 Dec; 19(6):615-22. PubMed ID: 17075339
[TBL] [Abstract][Full Text] [Related]
14. Drug evaluation: Albuferon-alpha--an antiviral interferon-alpha/albumin fusion protein.
Chemmanur AT; Wu GY
Curr Opin Investig Drugs; 2006 Aug; 7(8):750-8. PubMed ID: 16955687
[TBL] [Abstract][Full Text] [Related]
15. Use of placebo: is it a boon or bane?
Girish C
Gastroenterology; 2005 Mar; 128(3):805. PubMed ID: 15765430
[No Abstract] [Full Text] [Related]
16. Strategies for hepatitis C therapeutic intervention: now and next.
Tan SL; He Y; Huang Y; Gale M
Curr Opin Pharmacol; 2004 Oct; 4(5):465-70. PubMed ID: 15351350
[TBL] [Abstract][Full Text] [Related]
17. New hepatitis treatment decreases injections.
AIDS Patient Care STDS; 2003 Jan; 17(1):46. PubMed ID: 12622121
[No Abstract] [Full Text] [Related]
18. Inhibitors of hepatitis C virus NS3.4A protease 2. Warhead SAR and optimization.
Perni RB; Pitlik J; Britt SD; Court JJ; Courtney LF; Deininger DD; Farmer LJ; Gates CA; Harbeson SL; Levin RB; Lin C; Lin K; Moon YC; Luong YP; O'Malley ET; Rao BG; Thomson JA; Tung RD; Van Drie JH; Wei Y
Bioorg Med Chem Lett; 2004 Mar; 14(6):1441-6. PubMed ID: 15006379
[TBL] [Abstract][Full Text] [Related]
19. Non-nucleoside inhibitors of the HCV polymerase.
Sarisky RT
J Antimicrob Chemother; 2004 Jul; 54(1):14-6. PubMed ID: 15190019
[TBL] [Abstract][Full Text] [Related]
20. Novel interferons for treatment of hepatitis C virus.
Clark V; Nelson DR
Clin Liver Dis; 2009 Aug; 13(3):351-63. PubMed ID: 19628153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
